Oncolytics Biotech Statistics Share Statistics Oncolytics Biotech has 100.18M
shares outstanding. The number of shares has increased by 15.37%
in one year.
Shares Outstanding 100.18M Shares Change (YoY) 15.37% Shares Change (QoQ) 2.78% Owned by Institutions (%) 1.78% Shares Floating 98.78M Failed to Deliver (FTD) Shares 27,194 FTD / Avg. Volume 2.33%
Short Selling Information The latest short interest is 2.62M, so 2.58% of the outstanding
shares have been sold short.
Short Interest 2.62M Short % of Shares Out 2.58% Short % of Float 2.67% Short Ratio (days to cover) 1.44
Valuation Ratios The PE ratio is -3.17 and the forward
PE ratio is -3.47.
Oncolytics Biotech's PEG ratio is
0.
PE Ratio -3.17 Forward PE -3.47 PS Ratio 0 Forward PS 102.5 PB Ratio 16.8 P/FCF Ratio -3.69 PEG Ratio 0
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Oncolytics Biotech.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 2.82,
with a Debt / Equity ratio of 0.18.
Current Ratio 2.82 Quick Ratio 2.82 Debt / Equity 0.18 Debt / EBITDA -0.03 Debt / FCF -0.04 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-1.13M Employee Count 28 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax 130K Effective Tax Rate -0.41%
Stock Price Statistics The stock price has increased by 44.64% in the
last 52 weeks. The beta is 1.19, so Oncolytics Biotech's
price volatility has been higher than the market average.
Beta 1.19 52-Week Price Change 44.64% 50-Day Moving Average 1.12 200-Day Moving Average 0.8 Relative Strength Index (RSI) 57.48 Average Volume (20 Days) 1,169,349
Income Statement
Revenue n/a Gross Profit n/a Operating Income -34.98M Net Income -31.71M EBITDA -34.88M EBIT -34.98M Earnings Per Share (EPS) -0.41
Full Income Statement Balance Sheet The company has 15.94M in cash and 1.06M in
debt, giving a net cash position of 14.88M.
Cash & Cash Equivalents 15.94M Total Debt 1.06M Net Cash 14.88M Retained Earnings -477.71M Total Assets 19.97M Working Capital 12.34M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -26.97M
and capital expenditures -239K, giving a free cash flow of -27.2M.
Operating Cash Flow -26.97M Capital Expenditures -239K Free Cash Flow -27.2M FCF Per Share -0.36
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
Dividends & Yields ONCY does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for ONCY is $5,
which is 287.6% higher than the current price. The consensus rating is "Buy".
Price Target $5 Price Target Difference 287.6% Analyst Consensus Buy Analyst Count 5
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on May 25, 2018. It was a
backward
split with a ratio of 2:19.
Last Split Date May 25, 2018 Split Type backward Split Ratio 2:19
Scores Altman Z-Score -33.14 Piotroski F-Score 1
